Loading...
Patient-reported outcomes (PROs) with durvalumab by PD-L1 expression in unresectable, stage III NSCLC (PACIFIC)
Garassino, MC Paz-Ares, L Hui, R Faivre-Finn, Corinne Spira, A Planchard, D Ozguroglu, M Daniel, DB Vicente, D Murakami, S
Garassino, MC
Paz-Ares, L
Hui, R
Faivre-Finn, Corinne
Spira, A
Planchard, D
Ozguroglu, M
Daniel, DB
Vicente, D
Murakami, S
Citations
Altmetric:
Abstract
Description
Date
2019
Publisher
Collections
Files
Loading...
From UNPAYWALL
Adobe PDF, 68.71 KB
Keywords
Type
Meetings and Proceedings
Citation
Garassino MC, Paz-Ares L, Hui R, Faivre-Finn C, Spira A, Planchard D, et al. Patient-reported outcomes (PROs) with durvalumab by PD-L1 expression in unresectable, stage III NSCLC (PACIFIC). Ann Oncol. 2019;30 Suppl 2:ii78.